Downloaded from: justpaste.it/3qld4
Bharat Biotech asked to provide more data on Covaxin for below 12-year-olds This development comes after the Subject Expert Committee discussed recommendations for the restricted emergency of Covaxin in children aged between 212 years
New Delhi [India], April 22 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its COVID-19 vaccine, Covaxin, for administering it to children aged between 2-12 years, sources said. This development comes after the Subject Expert Committee discussed recommendations for...read more